First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake. (Q40625131)
Jump to navigation
Jump to search
scientific article published on 11 August 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake. |
scientific article published on 11 August 2016 |
Statements
First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake (English)
Neeta Pandit-Taskar
Shutian Ruan
Sarah M Cheal
Serge K Lyashchenko
Glenn Heller
Danny F Martinez
Steven M Larson
Martin Fleisher
Jennifer S Keppler
Robert E Reiter
Anna M Wu
Wolfgang A Weber
1 reference
1 reference
1 reference